AMLX vs ANIP: Side-by-Side Comparison
Compare Amylyx Pharmaceuticals Inc (AMLX) and ANI Pharmaceuticals Inc (ANIP) side by side: market cap USD 2.03B vs USD 1.96B. Financials, growth and model signals on Bullrun.
| Metric | AMLX | ANIP |
|---|---|---|
| Company | Amylyx Pharmaceuticals Inc | ANI Pharmaceuticals Inc |
| Country / Exchange | United States · NASDAQ | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Drug Manufacturers-Specialty & Generic |
| Market cap | USD 2.03B | USD 1.96B |
| P/E ratio | — | 21.8 |
| Dividend yield | — | — |
| Valuation model | — | 2.7% undervalued |
| Revenue (FY2025) | USD 0 | USD 883.37M |
| Revenue growth YoY | -100.0% | +43.8% |
| Net income | USD -144.74M | USD 78.00M |
| Gross margin | — | — |
| Diluted EPS | -1.53 | 3.32 |